Research: China’s experimental COVID-19 vaccine appears safe

All data obtained from this clinical trial supports the safety and immunogeneity of this inactivated vaccine and also encourages further research on the efficacy of the vaccine going forward.

Beijing (ANTARA) – China’s experimental COVID-19 vaccine developed by the Institute of Medical Biology, an institution under the Chinese Academy of Medical Sciences, appears safe in early-stage clinical trials, according to researchers.

In a Phase 1 clinical trial of 191 healthy participants aged 18 to 59 years, the group’s experimental injection of vaccination did not show severe negative reactions, he said in documents posted in the preprint journal medRxiv on Tuesday.

The most common negative reactions experienced by participants were mild pain, slight fatigue and redness, itching and swelling at the injection site.

The experimental vaccine also triggers an immune response.

Also read: Sinovac China hopes to analyze the final stage of the vaccine test data this year

Also read: Sinovac wants to supply more vaccines to South America

“All the data obtained from this clinical trial supports the safety and immunity of this inactivated vaccine and also encourages further research on the efficacy of the vaccine going forward,” the document states.

China is injecting hundreds of thousands of essential workers and other groups deemed particularly at risk with other vaccines, even as clinical trials are not yet fully completed, which has raised concerns among experts.

At least four experimental vaccines made in China are currently in the final stages of clinical trials.

Source: Reuters

Also read: China wants its vaccines to be assessed by WHO for global use

Also read: China promises to export the COVID-19 vaccine at a fair price

Translator: Asri Mayang Sari
Editor: Mulyo Sunyoto
COPYRIGHT © BETWEEN 2020

–